Antibody neutralization of the extracellular enveloped form of vaccinia virus

Virology

Volumn 280, Issue 1, 2001, Pages 132-142

  Law, Mansun ^a   Smith, Geoffrey L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Binding inhibition assay; EEV mutants; Extracellular enveloped virus (EEV); Plaque reduction assay; Vaccinia virus; Virus neutralization

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; GENE MUTATION; IMMUNOFLUORESCENCE; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN PURIFICATION; VACCINIA VIRUS; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

VACCINIA VIRUS;

EID: 0035261905     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0750     Document Type: Article

References (62)

1. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection
2. Fragmentation of immunoglobulin G
3. Neutralizing activities of antisera to poxvirus soluble antigens
4. An antigenic difference between intracellular and extracellular rabbitpox virus
5. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37000-Dalton outer envelope protein
6. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread
7. The nature of the immune state produced by inactivated vaccinia virus in rabbits
8. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies
9. Neutralization of animal viruses
10. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope
11. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence
12. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression
13. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens
14. A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope
15. Antibody-dependent enhancement of infection: A mechanism for indirect virus entry into cells
16. The enchancement of virus infectivity by antibody
17. Functional analysis of vaccinia virus B5R protein: Essential role in virus envelopment is independent of a large portion of the extracellular domain
18. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment
19. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells
20. Neutralization of poliovirus by a monoclonal antibody: Kinetics and stoichiometry
21. Extracellular enveloped vaccinia virus escapes neutralization
22. Neutralizing epitope on penetration protein of vaccinia virus
23. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope
24. A broadly active viral inhibitor in human and animal organ extracts and body fluids
25. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo
26. Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV
27. Structural and functional characterization of a cell surface binding protein of vaccinia virus
28. The immunogenicity of heat-inactivated vaccinia virus in rabbits
29. The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium
30. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation
31. Vaccinia virus glycoprotein A34R is required for infectivity of extracelluar enveloped virus
32. Poxviridae: The viruses and their replication
33. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus
34. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia
35. Adsorption and penetration of enveloped and naked vaccinia virus particles
36. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
37. IPTG-dependent vaccinia virus: Identification of a virus protein enabling virion envelopment by Golgi membrane and egress
38. A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus
39. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus
40. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation
41. 2+ influx into infected cells
42. Virus-induced cell motility
43. Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans-Golgi network
44. Biochemical analysis of the major vaccinia virus envelope antigen
45. Lipoproteins account for part of the broad non-specific antiviral activity of human serum
46. Extracellular enveloped vaccinia virus: Entry, egress, and evasion
47. Vaccinia virus immune evasion
48. Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins
49. Quantitative relationships between an influenza virus and neutralizing antibody
50. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes
51. Inactivated smallpox vaccine: Immunogenicity of inactivated intracellular and extracellular vaccinia virus
52. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells comet formation
53. Intracellular and extracellular vaccinia virions enter cells by different mechanisms
54. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope
55. A novel virus binding assay using confocal microscopy: Demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors
56. The vaccinia virus A36R protein is a type lb membrane protein present on intracellular but not extracellular enveloped virus particles
57. Neutralization of adenoviruses: Kinetics, stoichiometry, and mechanisms
58. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination
59. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies
60. The vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence
61. Identification of the gene encoding vaccinia virus immunodominant protein p35